Skip to main content
Erschienen in: Clinical and Experimental Nephrology 4/2016

28.10.2015 | Original Article

Heart rate variability is an indicator for intradialytic hypotension among chronic hemodialysis patients

verfasst von: Yu-Ming Chang, Chih-Chung Shiao, Kuo-Chi Chang, I-Ling Chen, Chuan-Lan Yang, Show-Chin Leu, Hung-Li Su, Jsun-Liang Kao, Shih-Ching Tsai, Rong-Na Jhen

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Intradialytic hypotension (IDH) carries adverse impact. Heart rate variability (HRV) represents autonomic cardiac regulation which influences intradialytic blood pressure. We aimed to evaluate the association between IDH and HRV.

Methods

This prospective study was carried out in a teaching hospital in Taiwan from June to August 2010. Adult patients on chronic hemodialysis without active medical conditions were enrolled and received HRV measurements for 4 times (before and during an index hemodialysis session). Patients were categorized by the changes of systolic blood pressure during the index hemodialysis into Group 1 (elevation >20 mmHg), Group 2 (decrease >20 mmHg), and Group 3 (others). Then we compared HRV indices among the three groups, and determined the indicators for IDH.

Results

One hundred and seventy-one patients (96 women, mean age 64.9 years) were enrolled and categorized into Group 1 (n = 47, 27.5 %), Group 2 (n = 45, 26.3 %) and Group 3 (n = 79, 46.2 %). Comparing with Group 1 and/or Group 3, Group 2 had significantly higher blood pressure at hemodialysis initiation (most p < 0.001) and statistically lower levels of HRV indices including variance, total power, very low-frequency, low-frequency and high-frequency since the middle phase of the hemodialysis. By logistic regression method, higher systemic blood pressure [odds ratio (OR) 1.048; p < 0.001], heart rate (OR 1.093; p = 0.021), low-frequency/high-frequency ratio (OR 1.715; p = 0.022), as well as lower variance (OR 0.639; p = 0.048) at hemodialysis initiation were independently associated with intradialytic blood pressure changes.

Conclusions

HRV is a useful indicator for IDH among hemodialysis patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1–153. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1–153.
2.
Zurück zum Zitat Ewing DJ, Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron. 1975;15(6):424–9.CrossRefPubMed Ewing DJ, Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron. 1975;15(6):424–9.CrossRefPubMed
3.
Zurück zum Zitat Daul AE, Wang XL, Michel MC, Brodde OE. Arterial hypotension in chronic hemodialyzed patients. Kidney Int. 1987;32(5):728–35.CrossRefPubMed Daul AE, Wang XL, Michel MC, Brodde OE. Arterial hypotension in chronic hemodialyzed patients. Kidney Int. 1987;32(5):728–35.CrossRefPubMed
4.
5.
Zurück zum Zitat Barnas MG, Boer WH, Koomans HA. Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension. J Am Soc Nephrol. 1999;10(12):2577–84.PubMed Barnas MG, Boer WH, Koomans HA. Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension. J Am Soc Nephrol. 1999;10(12):2577–84.PubMed
6.
Zurück zum Zitat Routledge HC, Chowdhary S, Townend JN. Heart rate variability—a therapeutic target? J Clin Pharm Ther. 2002;27(2):85–92.CrossRefPubMed Routledge HC, Chowdhary S, Townend JN. Heart rate variability—a therapeutic target? J Clin Pharm Ther. 2002;27(2):85–92.CrossRefPubMed
9.
Zurück zum Zitat Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Euro Heart J. 1996;17(3):354–81. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Euro Heart J. 1996;17(3):354–81.
11.
Zurück zum Zitat Pelosi G, Emdin M, Carpeggiani C, Morales MA, Piacenti M, Dattolo P, et al. Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability. Clin Sci (Lond). 1999;96(1):23–31.CrossRef Pelosi G, Emdin M, Carpeggiani C, Morales MA, Piacenti M, Dattolo P, et al. Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability. Clin Sci (Lond). 1999;96(1):23–31.CrossRef
12.
14.
Zurück zum Zitat Chen KY, Chen CL, Yang CC, Kuo TB. Cardiac autonomic dysregulation in patients with acute hepatitis. Am J Med Sci. 2006;332(4):164–7.CrossRefPubMed Chen KY, Chen CL, Yang CC, Kuo TB. Cardiac autonomic dysregulation in patients with acute hepatitis. Am J Med Sci. 2006;332(4):164–7.CrossRefPubMed
15.
Zurück zum Zitat Cavalcanti S, Severi S, Chiari L, Avanzolini G, Enzmann G, Bianco G, et al. Autonomic nervous function during haemodialysis assessed by spectral analysis of heart-rate variability. Clin Sci (Lond). 1997;92(4):351–9.CrossRef Cavalcanti S, Severi S, Chiari L, Avanzolini G, Enzmann G, Bianco G, et al. Autonomic nervous function during haemodialysis assessed by spectral analysis of heart-rate variability. Clin Sci (Lond). 1997;92(4):351–9.CrossRef
16.
Zurück zum Zitat Rubinger D, Revis N, Pollak A, Luria MH, Sapoznikov D. Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant. 2004;19(8):2053–60. doi:10.1093/ndt/gfh306.CrossRefPubMed Rubinger D, Revis N, Pollak A, Luria MH, Sapoznikov D. Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant. 2004;19(8):2053–60. doi:10.​1093/​ndt/​gfh306.CrossRefPubMed
17.
Zurück zum Zitat Forsstrom J, Heinonen E, Valimaki I, Antila K. Effects of haemodialysis on heart rate variability in chronic renal failure. Scand J Clin Lab Invest. 1986;46(7):665–70.CrossRefPubMed Forsstrom J, Heinonen E, Valimaki I, Antila K. Effects of haemodialysis on heart rate variability in chronic renal failure. Scand J Clin Lab Invest. 1986;46(7):665–70.CrossRefPubMed
19.
Zurück zum Zitat Ino-Oka E, Urae J, Sekino M, Satoh M, Takeuchi K, Sekino H, et al. Blood pressure and sympathetic nerve tone relation during hemodialysis may reflect cardiovascular dysfunction. Intern Med. 2011;50(22):2741–8.CrossRefPubMed Ino-Oka E, Urae J, Sekino M, Satoh M, Takeuchi K, Sekino H, et al. Blood pressure and sympathetic nerve tone relation during hemodialysis may reflect cardiovascular dysfunction. Intern Med. 2011;50(22):2741–8.CrossRefPubMed
20.
Zurück zum Zitat Cases A, Coll E. Chronic hypotension in the dialysis patient. J Nephrol. 2002;15(4):331–5.PubMed Cases A, Coll E. Chronic hypotension in the dialysis patient. J Nephrol. 2002;15(4):331–5.PubMed
21.
22.
Zurück zum Zitat Yamamoto K, Kobayashi N, Kutsuna T, Ishii A, Matsumoto T, Hara M, et al. Excessive fall of blood pressure during maintenance hemodialysis in patients with chronic renal failure is induced by vascular malfunction and imbalance of autonomic nervous activity. Ther Apher Dial. 2012;16(3):219–25. doi:10.1111/j.1744-9987.2011.01053.x.CrossRefPubMed Yamamoto K, Kobayashi N, Kutsuna T, Ishii A, Matsumoto T, Hara M, et al. Excessive fall of blood pressure during maintenance hemodialysis in patients with chronic renal failure is induced by vascular malfunction and imbalance of autonomic nervous activity. Ther Apher Dial. 2012;16(3):219–25. doi:10.​1111/​j.​1744-9987.​2011.​01053.​x.CrossRefPubMed
23.
26.
Zurück zum Zitat Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP. The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res. 2010;33(6):521–8. doi:10.1038/hr.2010.35.CrossRefPubMed Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP. The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res. 2010;33(6):521–8. doi:10.​1038/​hr.​2010.​35.CrossRefPubMed
27.
Zurück zum Zitat Kim YH, Ahmed MW, Kadish AH, Goldberger JJ. Characterization of the factors that determine the effect of sympathetic stimulation on heart rate variability. Pacing Clin Electrophysiol (PACE). 1997;20(8 Pt 1):1936–46.CrossRef Kim YH, Ahmed MW, Kadish AH, Goldberger JJ. Characterization of the factors that determine the effect of sympathetic stimulation on heart rate variability. Pacing Clin Electrophysiol (PACE). 1997;20(8 Pt 1):1936–46.CrossRef
29.
Zurück zum Zitat Yun JS, Ahn YB, Song KH, Yoo KD, Kim HW, Park YM, et al. The association between abnormal heart rate variability and a new onset of chronic kidney disease in patients with type 2 diabetes: a ten-year follow-up study. Diabetes Res Clin Pract. 2015;. doi:10.1016/j.diabres.2015.01.031.PubMed Yun JS, Ahn YB, Song KH, Yoo KD, Kim HW, Park YM, et al. The association between abnormal heart rate variability and a new onset of chronic kidney disease in patients with type 2 diabetes: a ten-year follow-up study. Diabetes Res Clin Pract. 2015;. doi:10.​1016/​j.​diabres.​2015.​01.​031.PubMed
30.
Zurück zum Zitat Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998;98(15):1510–6.CrossRefPubMed Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998;98(15):1510–6.CrossRefPubMed
31.
Zurück zum Zitat Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation. 1993;88(1):180–5.CrossRefPubMed Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation. 1993;88(1):180–5.CrossRefPubMed
32.
Zurück zum Zitat Wang YC, Yang CC, Bai YM, Kuo TB. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up. Neuropsychobiology. 2008;57(4):200–5. doi:10.1159/000149818.CrossRefPubMed Wang YC, Yang CC, Bai YM, Kuo TB. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up. Neuropsychobiology. 2008;57(4):200–5. doi:10.​1159/​000149818.CrossRefPubMed
33.
Zurück zum Zitat Castellanos A, Moleiro F, Chakko S, Acosta H, Huikuri H, Mitrani RD, et al. Heart rate variability in inappropriate sinus tachycardia. Am J Cardiol. 1998;82(4):531–4.CrossRefPubMed Castellanos A, Moleiro F, Chakko S, Acosta H, Huikuri H, Mitrani RD, et al. Heart rate variability in inappropriate sinus tachycardia. Am J Cardiol. 1998;82(4):531–4.CrossRefPubMed
34.
Zurück zum Zitat Singh JP, Larson MG, O’Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000;86(3):309–12.CrossRefPubMed Singh JP, Larson MG, O’Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000;86(3):309–12.CrossRefPubMed
35.
Zurück zum Zitat Malpas SC. Neural influences on cardiovascular variability: possibilities and pitfalls. Am J Physiol Heart Circ Physiol. 2002;282(1):H6–20.PubMed Malpas SC. Neural influences on cardiovascular variability: possibilities and pitfalls. Am J Physiol Heart Circ Physiol. 2002;282(1):H6–20.PubMed
Metadaten
Titel
Heart rate variability is an indicator for intradialytic hypotension among chronic hemodialysis patients
verfasst von
Yu-Ming Chang
Chih-Chung Shiao
Kuo-Chi Chang
I-Ling Chen
Chuan-Lan Yang
Show-Chin Leu
Hung-Li Su
Jsun-Liang Kao
Shih-Ching Tsai
Rong-Na Jhen
Publikationsdatum
28.10.2015
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 4/2016
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-015-1189-9

Weitere Artikel der Ausgabe 4/2016

Clinical and Experimental Nephrology 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.